| Fluorescence anisotropy of membrane fluidity probes in human erythrocytes incubated with anthracyclines and glutaraldehyde A Marczak Bioelectrochemistry 74 (2), 236-239, 2009 | 71 | 2009 |
| Induction of apoptosis in human ovarian cancer cells by new anticancer compounds, epothilone A and B A Rogalska, A Marczak, A Gajek, M Szwed, A Śliwińska, J Drzewoski, ... Toxicology in vitro 27 (1), 239-249, 2013 | 65 | 2013 |
| Participation of the ATR/CHK1 pathway in replicative stress targeted therapy of high-grade ovarian cancer P Gralewska, A Gajek, A Marczak, A Rogalska Journal of hematology & oncology 13, 1-16, 2020 | 55 | 2020 |
| Two drugs are better than one. A short history of combined therapy of ovarian cancer B Bukowska, A Gajek, A Marczak Contemporary Oncology/Współczesna Onkologia 19 (5), 350-353, 2015 | 41 | 2015 |
| Treatment of multiple myeloma and the role of melphalan in the era of modern therapies—Current research and clinical approaches A Poczta, A Rogalska, A Marczak Journal of clinical medicine 10 (9), 1841, 2021 | 40 | 2021 |
| The role of reactive oxygen species in WP 631-induced death of human ovarian cancer cells: a comparison with the effect of doxorubicin A Rogalska, A Gajek, M Szwed, Z Jóźwiak, A Marczak Toxicology in Vitro 25 (8), 1712-1720, 2011 | 40 | 2011 |
| Changes in the activities of antioxidant enzymes and reduced glutathione level in human erythrocytes exposed to selected brominated flame retardants M Jarosiewicz, A Krokosz, A Marczak, B Bukowska Chemosphere 227, 93-99, 2019 | 38 | 2019 |
| Two faces of autophagy in the struggle against cancer A Chmurska, K Matczak, A Marczak International Journal of Molecular Sciences 22 (6), 2981, 2021 | 37 | 2021 |
| Interaction of doxorubicin and idarubicin with red blood cells from acute myeloid leukaemia patients A Marczak, A Kowalczyk, A Wrzesień-Kus, T Robak, Z Jóźwiak Cell biology international 30 (2), 127-132, 2006 | 35 | 2006 |
| Structural modifications in the sugar moiety as a key to improving the anticancer effectiveness of doxorubicin M Denel-Bobrowska, A Marczak Life Sciences 178, 1-8, 2017 | 31 | 2017 |
| Doxorubicin–transferrin conjugate triggers pro-oxidative disorders in solid tumor cells M Szwed, D Wrona, KD Kania, A Koceva-Chyla, A Marczak Toxicology in Vitro 31, 60-71, 2016 | 27 | 2016 |
| PARP inhibitor resistance in ovarian cancer: Underlying mechanisms and therapeutic approaches targeting the ATR/CHK1 pathway Ł Biegała, A Gajek, A Marczak, A Rogalska Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1876 (2), 188633, 2021 | 26 | 2021 |
| The effect of catechol on human peripheral blood mononuclear cells (in vitro study) B Bukowska, J Michałowicz, A Marczak Environmental toxicology and pharmacology 39 (1), 187-193, 2015 | 26 | 2015 |
| Influence of pre-storage irradiation on the oxidative stress markers, membrane integrity, size and shape of the cold stored red blood cells A Antosik, K Czubak, A Gajek, A Marczak, R Glowacki, K Borowczyk, ... Transfusion Medicine and Hemotherapy 42 (3), 140-148, 2015 | 25 | 2015 |
| Epothilone B induces extrinsic pathway of apoptosis in human SKOV-3 ovarian cancer cells A Rogalska, A Gajek, A Marczak Toxicology in Vitro 28 (4), 675-683, 2014 | 24 | 2014 |
| Effects of phenol, catechol, chloro-and metylphenol on human erythrocyte membrane (in vitro). B Bukowska, A Marczak, J MichaŃowicz, K Wisniewska Polish Journal of Environmental Studies 18 (4), 2009 | 24 | 2009 |
| The combined effect of IDA and glutaraldehyde on the properties of human erythrocytes A Szwarocka, A Kowalczyk, D Łubgan, Z Jóźwiak International journal of pharmaceutics 220 (1-2), 43-51, 2001 | 24 | 2001 |
| PARP inhibition increases the reliance on ATR/CHK1 checkpoint signaling leading to synthetic lethality—an alternative treatment strategy for epithelial ovarian cancer cells … P Gralewska, A Gajek, A Marczak, M Mikuła, J Ostrowski, A Śliwińska, ... International journal of molecular sciences 21 (24), 9715, 2020 | 22 | 2020 |
| Damage to the cell antioxidative system in human erythrocytes incubated with idarubicin and glutaraldehyde A Marczak, Z Jóźwiak Toxicology in vitro 23 (6), 1188-1194, 2009 | 22 | 2009 |
| Chemical modification of melphalan as a key to improving treatment of haematological malignancies A Gajek, A Poczta, M Łukawska, V Cecuda-Adamczewska, J Tobiasz, ... Scientific Reports 10 (1), 4479, 2020 | 21 | 2020 |
